CXCR4 blockade attenuates hyperoxia-induced lung injury in neonatal rats

Neonatology

Volumn 107, Issue 4, 2015, Pages 304-311

  Drummond, Shelley ^a,b   Ramachandran, Shalini ^a,b   Torres, Eneida ^a,b   Huang, Jian ^a,b   Hehre, Dorothy ^a,b   Suguihara, Cleide ^a,b   Young, Karen C ^a,b  

^a Divisions of Neonatology   (Canada)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Bronchopulmonary dysplasia; CXCR4 blockade; Hyperoxia

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; MYELOPEROXIDASE; PLACEBO; PLERIXAFOR; CXCR4 PROTEIN, RAT; HETEROCYCLIC COMPOUND;

ALVEOLARIZATION; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CLINICAL EVALUATION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HISTOGENESIS; HYPEROXIA; LUNG ALVEOLUS; LUNG DYSPLASIA; LUNG FIBROSIS; LUNG INJURY; LUNG LAVAGE; LUNG STRUCTURE; MACROPHAGE; NEUTROPHIL COUNT; NEWBORN; NONHUMAN; PERINATAL PERIOD; PNEUMONIA; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; REGENERATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BRONCHOPULMONARY DYSPLASIA; COMPLICATION; DISEASE MODEL; HYPERTENSION, PULMONARY; INFLAMMATION; PATHOLOGY; SPRAGUE DAWLEY RAT;

RATTUS; RODENTIA;

ANIMALS; ANIMALS, NEWBORN; BRONCHOPULMONARY DYSPLASIA; DISEASE MODELS, ANIMAL; HETEROCYCLIC COMPOUNDS; HYPEROXIA; HYPERTENSION, PULMONARY; INFLAMMATION; PULMONARY ALVEOLI; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CXCR4;

EID: 84926176621     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000371835     Document Type: Article

References (24)

1. Philip AG: Bronchopulmonary dysplasia: then and now. Neonatology 2012; 102: 1-8.
2. Jobe AJ: The new BPD: an arrest of lung development. Pediatr Res 1999; 46: 641-643.
3. Munshi UK, Niu JO, Siddiq MM, Parton LA: Elevation of interleukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia. Ped Pulmonol 1997; 24: 331-336.
4. McGrath KE, Koniski AD, Maltby KM, Mc-Gann JK, Palis J: Embryonic expression and function of the chemokine SDF-1 and its receptor, CXCR4. Develop Biol 1999; 213: 442-456.
5. Ratajczak MZ, Majka M, Kucia M, Drukala J, Pietrzkowski Z, Peiper S, Janowska-Wieczorek A: Expression of functional CXCR4 by muscle satellite cells and secretion of SDF-1 by muscle-derived fibroblasts is associated with the presence of both muscle progenitors in bone marrow and hematopoietic stem/progenitor cells in muscles. Stem Cells 2003; 21: 363-371.
6. Deng C, Wang J, Zou Y, Zhao Q, Feng J, Fu Z, Guo C: Characterization of fibroblasts recruited from bone marrow-derived precursor in neonatal bronchopulmonary dysplasia mice. J Appl Physiol 2011; 111: 285-294.
7. Donzella GA, Schols D, Lin SW, Este JA, Nagashima KA, Maddon PJ, Allaway GP, Sakmar TP, Henson G, De Clercq E, Moore JP: AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor. Nat Med 1998; 4: 72-77.
8. Jujo K, Hamada H, Iwakura A, Thorne T, Sekiguchi H, Clarke T, Ito A, Misener S, Tanaka T, Klyachko E, et al: CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction. Proc Natl Acad Sci USA 2010; 107: 11008-11013.
9. Xu J, Mora A, Shim H, Stecenko A, Brigham KL, Rojas M: Role of the SDF-1/CXCR4 axis in the pathogenesis of lung injury and fibrosis. Am J Respir Cell Mol Biol 2007; 37: 291-299.
10. Lukacs NW, Berlin A, Schols D, Skerlj RT, Bridger GJ: AMD3100, a CXCR4 antagonist, attenuates allergic lung inflammation and airway hyperreactivity. Am J Pathol 2002; 160: 1353-1360.
11. Devine SM, Flomenberg N, Vesole DH, Liesveld J, Weisdorf D, Badel K, Calandra G, Di-Persio JF: Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma. J Clin Oncol 2004; 22: 1095-1102.
12. Thurlbeck WM: Measurement of pulmonary emphysema. Am Rev Respir Dis 1967; 95: 752-764.
13. Hummler SC, Rong M, Chen S, Hehre D, Alapati D, Wu S: Targeting glycogen synthase kinase-3? to prevent hyperoxia-induced lung injury in neonatal rats. Am J Resp Cell Mol Biol 2013; 48: 578-588.
14. Petty JM, Sueblinvong V, Lenox CC, Jones CC, Cosgrove GP, Cool CD, Rai PR, Brown KK, Weiss DJ, Poynter ME, Suratt BT: Pulmonary stromal-derived factor-1 expression and effect on neutrophil recruitment during acute lung injury. J Immunol 2007; 178: 8148-8157.
15. Balasubramaniam V, Mervis CF, Maxey AM, Markham NE, Abman SH: Hyperoxia reduces bone marrow, circulating, and lung endothelial progenitor cells in the developing lung: implications for the pathogenesis of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2007; 292:L1073-L1084.
16. Zuk A, Gershenovich M, Ivanova Y, MacFarland RT, Fricker SP, Ledbetter S: CXCR(4)antagonism as a therapeutic approach to prevent acute kidney injury. Am J Physiol Renal Physiol 2014; 307:F783-F797.
17. Ogden BE, Murphy SA, Saunders GC, Pathak D, Johnson JD: Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance. Am Rev Respir Dis 1984; 130: 817-821.
18. Devi S, Wang Y, Chew WK, Lima R, AGonzalez N, Mattar CNZ, Chong SZ, Schlitzer A, Bakocevic N, Chew S, et al: Neutrophil mobilization via plerixafor-mediated CXCR4 inhibition arises from lung demargination and blockade of neutrophil homing to the bone marrow. J Exp Med 2013; 210: 2321-2336.
19. Sohy D, Yano H, de Nadai P, Urizar E, Guillabert A, Javitch JA, Parmentier M, Springael JY: Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the protean effects of selective' antagonists. J Biol Chem 2009; 284: 31270-31279.
20. Zhang H, Trivedi A, Lee J-U, Lohela M, Lee SM, Fandel TM, Werb Z, Noble-Haeusslein LJ: Matrix metalloproteinase-9 and stromal cell-derived factor-1 act synergistically to support migration of blood-borne monocytes into the injured spinal cord. J Neuro 2011; 31: 15894-15903.
21. Yu X, Huang Y, Collin-Osdoby P, Osdoby P: Stromal cell-derived factor-1 (SDF-1) recruits osteoclast precursors by inducing chemotaxis, matrix metalloproteinase-9 (MMP-9) activity, and collagen transmigration. J Bone Miner Res 2003; 18: 1404-1418.
22. Cherukupalli K, Larson JE, Rotschild A, Thurlbeck WM: Biochemical, clinical, and morphologic studies on lungs of infants with bronchopulmonary dysplasia. Ped Pulmonol 1996; 22: 215-229.
23. Young KC, Torres E, Hatzistergos KE, Hehre D, Suguihara C, Hare JM: Inhibition of the SDF-1/CXCR4 axis attenuates neonatal hypoxia-induced pulmonary hypertension. Circ Res 2009; 104: 1293-1301.
24. Ghosh MC, Makena PS, Gorantla V, Sinclair SE, Waters CM: CXCR4 regulates migration of lung alveolar epithelial cells through activation of Rac1 and matrix metalloproteinase-2. Am J Physiol Lung Cell Mol Physiol 2012; 302:L846-L856.